Tag: life sciences
-
Controlled Brain Tumor Gene Therapy Shown Safe
A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer.
-
Nanotube Fibers Configured for Heart Repair
Medical and engineering researchers developed fibers made with nanoscale carbon tubes that in lab animals conducted electrical signals and repaired heart damage.
-
Neuro Stimulation Reduces Stroke Muscle Weakness
A clinical trial shows a non-invasive device stimulating the spinal cord and upper limb muscles reduces spasticity and muscle weakness in people who suffered a stroke.
-
Trial Shows Two Drugs Can Treat Ebola Virus
A clinical trial in the Congo shows two different therapies made with synthetic antibodies are better able to treat Ebola infections than two other drugs tested.
-
Engineered Bacteria Hydrogels Designed for Gut Repair
Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces.
-
MD Anderson, Drug Maker Partner on Lung, GI Cancers
MD Anderson Cancer Center and drug maker Boehringer Ingelheim agreed to jointly develop new treatments for lung and gastrointestinal cancers.
-
Food Technology Company Gains $4M in Seed Funds
A company developing a food preservation technology from university materials science labs is raising $4 million in its seed funding round.
-
Darpa Funds Early Disease Detection System
The Defense Department’s advanced research agency is underwriting a system that gives an earlier notice of disease outbreaks and pandemics than current methods.
-
Spray-On Hydrogel Reduces Heart Surgery Scar Tissue
A biocompatible polymer gel, sprayed on the hearts of lab animals, reduces the severity of scar tissue that can build up after cardiac surgery.
-
FDA Investigating Data Manipulation in Gene Therapy Approval
The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease.